Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-155965

Options or other derivatives

  • Chief Legal Officer acquired 97,066 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2016-12-15 Grant or award · Stock option (right to buy) +83,200 83,200 D: show line 1 in the form
Ali-Jackson Kamil Chief Legal Officer 2016-12-15 Grant or award · Restricted stock units +13,866 13,866 D: show line 2 in the form
Loading xslF345X03/doc4.xml…